The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Factor VII and Fibrinogen Levels as Risk Factors for Venous Thrombosis: A Case-Control Study of Plasma Levels and DNA Polymorphisms - The Leiden Thrombophilia Study (LETS)
Abstract
Summary: The plasma levels of coagulation factor VII and fibrinogen are well known risk factors for arterial thrombosis. We tested the hypothesis that this association also exists for venous thrombosis. Additionally, MspI and Haelll polymorphisms in the factor VII and fibrinogen genes have recently been reported to be associated with the concentration of both proteins in the plasma. However, no conclusion could be drawn with respect to an increase or decrease in thrombosis risk. We undertook a population-based case-control study, in which 199 patients with a first, objectively confirmed episode of deep vein thrombosis, aged less than 70, and without a known malignant disorder were compared to 199 age-and sex-matched healthy controls, to evaluate the clinical importance of these reported findings. For fibrinogen we found a positive level-related association between the plasma fibrinogen level and thrombotic risk. Subjects with a plasma fibrinogen greater than 5 g/1 had an almost 4-fold increase of thrombosis risk. The frequencies of the different Haelll genotypes were out of balance only for the thrombosis patients, with a deficit of the H1H2 genotype. Possession of an H1H2 genotype was associated with a 40% reduction in thrombosis risk. For factor VII, neither the plasma level nor the MspI genotypes were related to deep vein thrombosis, although possession of a M2 allele was clearly associated with significantly lower factor VII levels. The frequencies of the Mspl-genotypes were the same for patients and control subjects and, exhibited Hardy-Weinberg equilibrium. Our results support that plasma fibrinogen, a determinant of arterial thrombosis is also a risk factor for venous thrombosis, while factor VII plasma concentration is unrelated to deep vein thrombosis, which is supported by the data from the DNA analysis of polymorphisms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fibrinogen as a Risk Factor for Stroke and Myocardial Infarction
Wilhelmsen, L., Svärdsudd, K., Korsan-Bengtsen, K., Larsson, B., Welin, L., & Tibblin, G. (1984) · New England Journal of Medicine · doi:10.1056/nejm198408233110804 · Cited by 1,646
Fibrinogen and Risk of Cardiovascular Disease: The Framingham Study
Kannel, W. B. (1987) · JAMA · doi:10.1001/jama.1987.03400090067035 · Cited by 886
Fibrinogen and risk of cardiovascular disease
Nguyen, V. (1988) · Annals of Emergency Medicine · doi:10.1016/s0196-0644(88)80530-4 · Cited by 593
Bleeding complications in oral anticoagulant therapy. An analysis of risk factors
van der Meer, F. J. (1993) · Archives of Internal Medicine · doi:10.1001/archinte.153.13.1557 · Cited by 538
Characteristics affecting fibrinolytic activity and plasma fibrinogen concentrations.
Meade, T. W., Chakrabarti, R., Haines, A. P., North, W. R., & Stirling, Y. (1979) · BMJ · doi:10.1136/bmj.1.6157.153 · Cited by 410
Balleisen, L., Bailey, J., Epping, P.-H., Schulte, H., & van de Loo, J. (1985) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1657877 · Cited by 346
Green, F., Kelleher, C., Wilkes, H., Temple, A., Meade, T., & Humphries, S. (1991) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.11.3.540 · Cited by 275
Humphries, S. E., Dubowitz, M., Cook, M., Stirling, Y., & Meade, T. W. (1987) · The Lancet · doi:10.1016/s0140-6736(87)92205-7 · Cited by 231
Thomas, A. E., Green, F. R., Kelleher, C. H., Wilkes, H. C., Brennan, P. J., Meade, T. W., & Humphries, S. E. (1991) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1648177 · Cited by 172
Scarabin, P., Bara, L., Ricard, S., Poirier, O., Cambou, J., Arveiler, D., Luc, G., Evans, A. E., Samama, M. M., & Cambien, F. (1993) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.13.6.886 · Cited by 123
Cited by
Genetic Susceptibility to Venous Thrombosis
Seligsohn, U., & Lubetsky, A. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104193441607 · Cited by 822
High Levels of Coagulation Factor XI as a Risk Factor for Venous Thrombosis
Meijers, J. C. M., Tekelenburg, W. L. H., Bouma, B. N., Bertina, R. M., & Rosendaal, F. R. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003093421004 · Cited by 700
Self-citationThrombophilia, Clinical Factors, and Recurrent Venous Thrombotic Events
Christiansen, S. C. (2005) · JAMA · doi:10.1001/jama.293.19.2352 · Cited by 586
How it all starts: Initiation of the clotting cascade
Smith, S. A., Travers, R. J., & Morrissey, J. H. (2015) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2015.1050550 · Cited by 529
Physical Activity and Hemostatic and Inflammatory Variables in Elderly Men
Wannamethee, S. G., Lowe, G. D. O., Whincup, P. H., Rumley, A., Walker, M., & Lennon, L. (2002) · Circulation · doi:10.1161/01.cir.0000016346.14762.71 · Cited by 487
Metadata
- Authors
- Koster, T., Rosendaal, F. R., Reitsma, P. H., Velden, P. A. V. D., Briët, E., & Vandenbroucke, J. P.
- Venue
- Thrombosis and Haemostasis
- Publisher
- Georg Thieme Verlag KG
- Published
- 1994
- Volume
- 71
- Issue
- 06
- Pages
- 719-722
- ISSN
- 0340-6245 (ISSN-L)
- 2567-689X
- OpenAlex
- W2110474655
- Cited by
- 293
- References
- 14
- FWCI
- 3.89
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Factor VII and Fibrinogen Levels as Risk Factors for Venous Thrombosis: A Case-Control Study of Plasma Levels and DNA Polymorphisms - The Leiden Thrombophilia Study (LETS). https://app.cochat.ai/papers/10.1055/s-0038-1642511
- The paper
- Koster, T., Rosendaal, F. R., Reitsma, P. H., Velden, P. A. V. D., Briët, E., & Vandenbroucke, J. P. (1994). Factor VII and Fibrinogen Levels as Risk Factors for Venous Thrombosis: A Case-Control Study of Plasma Levels and DNA Polymorphisms - The Leiden Thrombophilia Study (LETS). Thrombosis and Haemostasis. https://doi.org/10.1055/s-0038-1642511
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.